SCOPUS 정보 검색 플랫폼

Journal of Psychopharmacology

Volumn 23, Issue 2, 2009, Pages 206-210

Clozapine: More than 900?mg/day may be needed

(6) MacCall, C a Billcliff, N a Igbrude, W b Natynczuk, S c Spencer, E P d Flanagan, R J d

a The State Hospital (United Kingdom)

b Wonford House Hospital (United Kingdom)

c Newtown Hospital (United Kingdom)

d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST (United Kingdom)

Author keywords

Clozapine; Cytochrome P450; Schizophrenia

Indexed keywords

CLOZAPINE; NORCLOZAPINE; CYTOCHROME P450; DRUG DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CIGARETTE SMOKING; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MEGADOSE; DRUG METABOLISM; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT FAILURE; UNITED KINGDOM; BLOOD; CASE REPORT; DRUG ADMINISTRATION; DRUG INTERACTION; METABOLISM; SCHIZOPHRENIA; SMOKING;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CYTOCHROME P-450 ENZYME SYSTEM; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; HUMANS; MALE; SCHIZOPHRENIA; SEX FACTORS; SMOKING;

EID: 67651110483 PISSN: 02698811 EISSN: 14617285 Source Type: Journal
DOI: 10.1177/0269881108089819 Document Type: Article

Times cited : (17)

References (6)

1
- 0034822941
- Unanticipated plasma concentrations in two clozapine-treated patients.
- Alfaro CL, McClure RK, Vertrees JE, Benavides R, (2001) Unanticipated plasma concentrations in two clozapine-treated patients. Ann Pharmacother 35: 1028 - 1031.
- (2001) Ann Pharmacother , vol.35 , pp. 1028-1031
- Alfaro, C.L.¹ McClure, R.K.² Vertrees, J.E.³ Benavides, R.⁴

2
- 26844507816
- Clozapine toxicity associated with smoking cessation: Case report.
- Derenne JL, Baldessarini RJ, (2005) Clozapine toxicity associated with smoking cessation: case report. Am J Ther 12: 469 - 471.
- (2005) Am J Ther , vol.12 , pp. 469-471
- Derenne, J.L.¹ Baldessarini, R.J.²

3
- 1642410948
- Nonresponse to clozapine and ultrarapid CYP1A2 activity: Clinical data and analysis of CYP1A2 gene.
- Eap CB, Bender S, Jaquenoud SE, Cucchia G, Jonzier-Perey M, Baumann P, Allorge D, Broly F, (2004) Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene. J Clin Psychopharmacol 24: 214 - 219.
- (2004) J Clin Psychopharmacol , vol.24 , pp. 214-219
- Eap, C.B.¹ Bender, S.² Jaquenoud, S.E.³ Cucchia, G.⁴ Jonzier-Perey, M.⁵ Baumann, P.⁶ Allorge, D.⁷ Broly, F.⁸

4
- 0023812652
- Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
- Kane J, Honigfeld G, Singer J, Meltzer H, (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatr 45: 789 - 796.
- (1988) Arch Gen Psychiatr , vol.45 , pp. 789-796
- Kane, J.¹ Honigfeld, G.² Singer, J.³ Meltzer, H.⁴

5
- 1642457270
- Influence of dose, cigarette smoking, age, sex and metabolic activity on plasma clozapine concentrations: A predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.
- Rostami-Hodjegan A, Amin AM, Spencer EP, Lennard MS, Tucker GT, Flanagan RJ, (2004) Influence of dose, cigarette smoking, age, sex and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients. J Clin Psychopharmacol 24: 70 - 78.
- (2004) J Clin Psychopharmacol , vol.24 , pp. 70-78
- Rostami-Hodjegan, A.¹ Amin, A.M.² Spencer, E.P.³ Lennard, M.S.⁴ Tucker, G.T.⁵ Flanagan, R.J.⁶

6
- 0043205845
- What is an adequate trial with clozapine? Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia.
- Schulte P, (2003) What is an adequate trial with clozapine? Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia. Clin Pharmacokinet 42: 607 - 618.
- (2003) Clin Pharmacokinet , vol.42 , pp. 607-618
- Schulte, P.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.